Continuous advancements in monoclonal antibody technologies are enhancing the effectiveness of antibody drug conjugates. Researchers are focusing on improving specificity and reducing side effects.
The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering a strong CAGR of 21.3% during...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek